Comprehensive suppression of all apoptosis-induced proliferation pathways as a proposed approach to colorectal cancer prevention and therapy

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Bordonaro, Michael ^a   Drago, Eric ^a   Atamna, Wafa ^b   Lazarova, Darina L ^a  

^a Janet Weis Children s Hospital   (United States)

^b California Northstate University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 TERT BUTYL 9 FLUORO 3,6 DIHYDRO 7H BENZ[H]IMIDAZO[4,5 F]ISOQUINOLIN 7 ONE; 8 [4 (1 AMINOCYCLOBUTYL)PHENYL] 9 PHENYL 1,2,4 TRIAZOLO[3,4 F][1,6]NAPHTHYRIDIN 3(2H) ONE; ANTINEOPLASTIC AGENT; BUTYRIC ACID; CAFFEIC ACID PHENETHYL ESTER; COFFEE EXTRACT; FLUOROURACIL; INHIBITOR COCKTAIL OF APOPTOSIS INDUCED PROLIFERATION; PANOBINOSTAT; PLANT EXTRACT; PROPOLIS; SELUMETINIB; UNCLASSIFIED DRUG; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; INDOLE DERIVATIVE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY FIBER; DRUG POTENTIATION; DRUG RESPONSE; DRUG TARGETING; EMBRYO; FETUS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; COLORECTAL NEOPLASMS; DIETARY SUPPLEMENT; DRUG EFFECTS; GENETICS; PATHOLOGY; TUMOR CELL LINE; WNT SIGNALING PATHWAY;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DIETARY SUPPLEMENTS; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; INDOLES; PROPOLIS; WNT SIGNALING PATHWAY;

EID: 84916898081     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115068     Document Type: Article

References (47)

1. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics. CA Cancer J Clin 64: 9-29.
2. Weinstein B, Joe A (2008) Oncogene Addiction. Cancer Res 68: 3077-3088.
3. Murugaesu N, Chew SK, Swanton C (2013) Adapting clinical paradigms to the challenges of cancer clonal evolution. Am J Pathol 182: 1962-1971.
4. Das Thakur M, Salangsang F, Landman AS, Sellers WR, Pryer NK, et al. (2013) Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance. Nature 494: 251-255.
5. Suda K, Tomizawa K, Osada H, Maehara Y, Yatabe Y, et al. (2012) Conversion from the "oncogene addiction" to "drug addiction" by intensive inhibition of the EGFR and MET in lung cancer with activating EGFR mutation. Lung Cancer 76: 292-299.
6. Valerie K, Yacoub A, Hagan MP, Curiel DT, Fisher PB, et al. (2007) Radiation-induced cell signaling: inside-out and outside-in. Mol Cancer Ther 6: 789-801.
7. Lazarova DL, Bordonaro M, Carbone R, Sartorelli AC (2004) Linear relationship between WNT activity levels and apoptosis in colorectal carcinoma cells exposed to butyrate. Inter. J. Cancer 110: 523-531.
8. Bordonaro M, Lazarova DL, Sartorelli AC (2007) The activation of beta-catenin by Wnt signaling mediates the effects of histone deacetylase inhibitors. Exp Cell Res 313: 1652-1666.
9. Bordonaro M, Tewari S, Atamna W, Lazarova DL (2011) The Notch Ligand Delta-Like 1 Integrates Inputs from TGFBeta/Activin and Wnt Pathways. Exp Cell Res 317: 1368-1381.
10. Schweisguth F (2004) Regulation of Notch signaling activity. Curr Biol 14: R129-R138.
11. Crosnier C, Vargesson N, Gschmeissner S, Ariza-McNaughton L, Morrison A, et al. (2005) Delta-Notch signalling controls commitment to a secretory fate in the zebrafish intestine. Development 132: 1093-1104.
12. Brabletz T, Jung A, Hermann K, Günther K, Hohenberger W, et al. (1998) Nuclear overexpression of the oncoprotein β-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract 194: 701-704.
13. Hlubek F, Brabletz T, Budczies J, Pfeiffer S, Jung A, et al. (2007) Heterogeneous expression of Wnt/beta-catenin target genes within colorectal cancer. Int J Cancer 121: 1941-1948.
14. Verras M, Papandreou I, Lim AL, Denko NC (2008) Tumor hypoxia blocks Wnt processing and secretion through the induction of endoplasmic reticulum stress. Mol Cell Biol 28: 7212-7224.
15. Huang D, Du X (2008) Crosstalk between tumor cells and microenvironment via Wnt pathway in colorectal cancer dissemination. World J Gastroenterol 14: 1823-1837.
16. Huh JR, Guo M, Hay BA (2004) Apoptosis-induced proliferation induced by cell death in the Drosophila wing disc requires activity of the apical cell death caspase Dronc in a nonapoptotic role. Curr. Biol 14: 1262-1266.
17. Perez-Garijo A, Martin FA, Morata G (2004) Caspase inhibition during apoptosis causes abnormal signalling and developmental aberrations in Drosophila. Development 131: 5591-5598.
18. Ryoo HD, Gorenc T, Steller H (2004) Apoptotic cells can induce compensatory cell proliferation through the JNK and the Wingless signaling pathways. Dev Cell. 7: 491-501.
19. Bergmann A, Steller H (2010) Apoptosis, stem cells, and tissue regeneration. Sci Signal 3(145):re8.
20. Kondo S (1988) Altruistic cell suicide in relation to radiation hormesis. Int J Radiat Biol Relat Stud Phys Chem Med 53: 95-102.
21. Fan Y, Bergmann A (2008) Apoptosis-induced apoptosis-induced proliferation. The Cell is dead. Long live the Cell! Trends Cell Biol18: 467-473.
22. Bordonaro M, Tewari S, Cicco CE, Atamna W, Lazarova DL (2011) A switch from canonical to noncanonical Wnt signaling mediates drug resistance in colon cancer cells. PLoS One 6: e27308.
23. Richter M, Jurek D, Wrba F, Kaserer K, Wurzer G, et al. (2002) Cells obtained from colorectal microadenomas mirror early premalignant growth patterns in vitro. Euro J Cancer 38: 1937-1945.
24. Kautenberger T, Beyer-Sehlmeyer G, Festag G, Haag N, Kuhler S, et al. (2005) The gut fermentation product butyrate, a chemopreventive agent, suppresses glutathione S-transferase theta (hGSTT1) and cell growth more in human colon adenoma cells (LT97) than tumor (HT29) cells. J Cancer Res Clin Oncol 131: 692-700.
25. Lazarova DL, Bordonaro M, Sartorelli AC (2001) Transcriptional regulation of the vitamin D3 receptor gene by ZEB. Cell Growth Differ 12: 319-326.
26. Drago E, Bordonaro M, Lee S, Atamna W, Lazarova DL (2013) Propolis Augments Apoptosis Induced by Butyrate via Targeting Cell Survival Pathways. PLoS One 8(9): e73151.
27. Yap TA, Yan L, Patnaik A, Fearen I, Olmos D, et al. (2011) First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors. J Clin Oncol 29: 4688-4695.
28. Adjei AA, Cohen RB, Franklin W, Morris C, Wilson D, et al. (2008) Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers. J Clin Oncol 26: 2139-2146.
29. Davies BR, Logie A, McKay JS, Martin P, Steele S, et al. (2007) AZD6244 (ARRY-142886), a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases: mechanism of action in vivo, pharmacokinetic/pharmacodynamic relationship, and potential for combination in preclinical models. Mol Cancer Ther 6: 2209-2219.
30. Yeh TC, Marsh V, Bernat BA, Ballard J, Colwell H, et al. (2007) Biological characterization of ARRY-142886 (AZD6244), a potent, highly selective mitogen-activated protein kinase kinase 1/2 inhibitor. Clin Cancer Res 13: 1576-1583.
31. World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Interim Report Summary. Food, Nutrition, Physical Activity, and the Prevention of Colorectal Cancer. 2011. Available at http://www.wcrf.org/PDFs/Colorectal%20cancer%20report%20summary%202011.pdf, accessed on May 11, 2013.
32. Lazarova D, Lee A, Wong T, Marian B, Chiaro C, et al. (2014) Modulation of Wnt activity and cell physiology by butyrate in LT97 microadenoma cells. J Cancer 5: 203-213.
33. Stalmach A, Steiling H, Williamson G, Crozier A (2010) Bioavailability of chlorogenic acids following acute ingestion of coffee by humans with an ileostomy. Arch Biochem Biophys 501: 98-105.
34. Schiller C, Fröhlich CP, Giessmann T, Siegmund W, Mönnikes H, et al. (2005) Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Aliment Pharmacol Ther 22: 971-997.
35. Ryoo HD, Bergmann A (2012) The role of apoptosis-induced proliferation for regeneration and cancer. Cold Spring Harb Perspect Biol 4: a008797.
36. Holt SV, Logié A, Odedra R, Heier A, Heaton SP, et al. (2012) The MEK1/2 inhibitor, selumetinib (AZD6244; ARRY-142886), enhances anti-tumour efficacy when combined with conventional chemotherapeutic agents in human tumour xenograft models. Br J Cancer 106: 858-866.
37. Dent P, Curiel DT, Fisher PB, Grant S (2009) Synergistic combinations of signaling pathway inhibitors: mechanisms for improved cancer therapy. Drug Resist Updat 12: 65-73.
38. Sobočanec S, Balog T, Šarič A, Mačak-Šafranko Ž, Štroser M, et al. (2011) Antitumor effect of Croatian propolis as a consequence of diverse sex-related dihydropyrimidine dehydrogenase (DPD) protein expression. Phytomedicine 18: 852-858.
39. Suzuki I, Hayashi I, Takaki T, Groveman DS, Fujimiya Y (2002) Antitumor and anticytopenic effects of aqueous extracts of propolis in combination with chemotherapeutic agents. Cancer Biother Radiopharm 17: 553-562.
40. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM236669.pdf, accessed on 12/09/2013.
41. Sinha R, Cross AJ, Daniel CR, Graubard BI, Wu JW, et al. (2012) Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study. Am J Clin Nutr 96: 374-381.
42. Wang ZJ, Ohnaka K, Morita M, Toyomura K, Kono S, et al. (2013) Dietary polyphenols and colorectal cancer risk: the Fukuoka colorectal cancer study. World J Gastroenterol 19: 2683-2690.
43. Kang NJ, Lee KW, Kim BH, Bode AM, Lee HJ, et al. (2011) Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPK. Carcinogenesis 32: 921-928.
44. Shen T, Lee J, Lee E, Kim SH, Kim TW, et al. (2010) Cafestol, a coffee-specific diterpene, is a novel extracellular signal-regulated kinase inhibitor with AP-1-targeted inhibition of prostaglandin E2 production in lipopolysaccharide-activated macrophages. Biol Pharm Bull 33: 128-132.
45. Ludwig IA, Clifford MN, Lean ME, Ashihara H, Crozier A (2014) Coffee: biochemistry and potential impact on health. Food Funct. 5: 1695-717.
46. Cagnol S, Chambard JC (2010) ERK and cell death: mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence. FEBS J 277: 2-21.
47. Baena Ruiz R, Salinas Hernández P (2014) Diet and cancer: risk factors and epidemiological evidence. Maturitas. 77: 202-8.